fibromyalgia

fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and cognitive impairment, often affecting individuals with a history of trauma, stress, or infection, as seen in patients treated by National Institutes of Health and World Health Organization. The condition is often comorbid with depression, anxiety disorders, and irritable bowel syndrome, as noted by American Psychological Association and Mayo Clinic. Researchers at Harvard University and Stanford University have made significant contributions to the understanding of the condition, which affects millions of people worldwide, including Lady Gaga and Morgan Freeman. The diagnosis and treatment of the condition have been extensively studied by Centers for Disease Control and Prevention and European Medicines Agency.

Definition and Diagnosis

The definition and diagnosis of fibromyalgia have been established by American College of Rheumatology and World Health Organization, which emphasize the importance of a comprehensive medical history and physical examination, as practiced by Johns Hopkins University and University of California, Los Angeles. The diagnosis is often made by rheumatologists, primary care physicians, and pain management specialists, who may use imaging studies and laboratory tests to rule out other conditions, such as Lupus and Rheumatoid arthritis, as seen in patients treated by Cleveland Clinic and Massachusetts General Hospital. The Widespread Pain Index and Symptom Severity Scale are commonly used to assess the severity of symptoms, as developed by National Institute of Arthritis and Musculoskeletal and Skin Diseases and European League Against Rheumatism.

Causes and Risk Factors

The causes and risk factors of fibromyalgia are not fully understood, but research suggests that genetic predisposition, hormonal changes, and environmental factors may play a role, as studied by University of Oxford and Karolinska Institutet. Individuals with a family history of the condition, such as those with a history of chronic fatigue syndrome and temporomandibular joint disorder, may be more likely to develop fibromyalgia, as noted by National Institute of Neurological Disorders and Stroke and American Academy of Sleep Medicine. Trauma, stress, and infection may also trigger the onset of symptoms, as seen in patients treated by NewYork-Presbyterian Hospital and University of California, San Francisco. Researchers at University of Cambridge and University of Toronto have made significant contributions to the understanding of the condition's causes and risk factors.

Symptoms and Classification

The symptoms of fibromyalgia can vary widely, but common complaints include widespread pain, fatigue, sleep disturbances, and cognitive impairment, as noted by American Academy of Neurology and National Sleep Foundation. The condition is often classified into different subtypes, such as fibromyalgia syndrome and chronic widespread pain, as developed by International Association for the Study of Pain and European Pain Federation. The Fibromyalgia Severity Scale is commonly used to assess the severity of symptoms, as studied by University of Michigan and Duke University. Researchers at University of California, Berkeley and University of Illinois at Urbana-Champaign have made significant contributions to the understanding of the condition's symptoms and classification.

Pathophysiology

The pathophysiology of fibromyalgia is not fully understood, but research suggests that abnormalities in pain processing and dysregulation of the hypothalamic-pituitary-adrenal axis may play a role, as studied by National Institute of Mental Health and University of Pennsylvania. Neurotransmitter imbalance, such as serotonin and dopamine dysregulation, may also contribute to the development of symptoms, as noted by American Psychiatric Association and Society for Neuroscience. Researchers at University of Chicago and University of Wisconsin-Madison have made significant contributions to the understanding of the condition's pathophysiology.

Treatment and Management

The treatment and management of fibromyalgia often involve a multidisciplinary approach, including pharmacological interventions, physical therapy, and cognitive-behavioral therapy, as practiced by Columbia University and University of Washington. Medications such as pregabalin and duloxetine may be used to manage pain and other symptoms, as developed by Pfizer and Eli Lilly and Company. Alternative therapies, such as acupuncture and yoga, may also be beneficial, as noted by National Center for Complementary and Integrative Health and American Holistic Health Association. Researchers at University of North Carolina at Chapel Hill and University of Southern California have made significant contributions to the development of effective treatment and management strategies.

Epidemiology

The epidemiology of fibromyalgia is not fully understood, but research suggests that the condition affects millions of people worldwide, including United States, Europe, and Australia, as noted by World Health Organization and Centers for Disease Control and Prevention. The condition is more common in women than men, and often co-occurs with other conditions, such as depression and anxiety disorders, as seen in patients treated by Massachusetts General Hospital and University of California, Los Angeles. Researchers at Harvard University and Stanford University have made significant contributions to the understanding of the condition's epidemiology, which is essential for the development of effective prevention and treatment strategies. Category:Chronic pain